RECOVERY Trial: In patients admitted to hospital with COVID-19 | Critical Care & Emergencies
RECOVERY Trial: In patients admitted to hospital with COVID-19, Colchicine did not reduce 28-day mortality, duration of hospital stay, or risk of progressing to invasive mechanical ventilation or death.